Table I.
Treatment | PAD4+/+ | PAD4−/− | ||||
Histone citrullination | Enlarged nucleusab | NET formationcd | Histone citrullination | Enlarged nucleus | NET formation | |
Control | 3.7 ± 0.3%e | UDf | UD | UD | UD | UD |
LPS | 42.3 ± 3.9%e | 23.4 ± 2.7%e | 9.5 ± 0.5%e | UD | UD | UD |
Cl-amidinef → LPS | 8.1 ± 1.3%e | 1.2 ± 0.2%e | 0.32 ± 0.3%e | UD | UD | UD |
PMA | 48.5 ± 3%e | 10.9 ± 0.3%e | 2.7 ± 0.5%e | UD | UD | UD |
H2O2 | 48.3 ± 5.4%e | 13.4 ± 1.4%e | 3 ± 0.3%e | UD | UD | UD |
U.D., undetectable.
The nucleus is scored as an enlarged nucleus if its nuclear diameter is >1.5-fold larger than a regular neutrophil, which is ∼10 µm in diameter.
Enlarged nuclei were found to be histone citrullination positive.
NET formation is scored if chromatin has extruded and elongated from the nucleus to extracellular space and is confirmed by neutrophil elastase staining after LPS treatment.
NETs were found to be histone citrullination positive.
Averages and standard deviations were shown (three independent experiments, >500 cells were counted from each experiment).
200 µM Cl-amidine was used to treat neutrophils for 30 min before LPS treatment for 3 h.